mavacamten
bms
['hcm', 'valor-hcm', 'mavacamten']
#originalreseach #simpub #aha2022 #circaha22 in valor-hcm, myosin inhibition with mavacamten reduced the need for septal reduction therapy at 32 weeks with lvot gradients quality of life, and positive cardiac remodeling #ahajournals 
RT/follows do not imply endorsement.